Live Nation Monopoly
LYV Sept puts
The Trade
A block of 1,900 LYV Sep 18, 2026 $105 puts sold for $1.00.
The strike is meaningfully below the 52-week low.
Why I Like It
1. The bad news already happened
On April 15, 2026, a federal jury in Manhattan found that Live Nation and Ticketmaster operated as an illegal monopoly. This was the headline event that ticketing-industry bears have been waiting on for years.
The stock’s reaction? Down ~7% on the day of the verdict, then a sharp V-recovery. After today’s Q1 print, LYV is trading at $169, well above the pre-verdict price. The market has moved on.
The remedies trial is still ahead, and a forced breakup remains theoretically possible, but price action like this is the market telling you it has already priced in some flavor of structural relief.
For a put-seller looking out to September, the most important catalyst on the calendar has already been digested. That doesn’t make it a non-risk, it makes it a known risk, which is exactly what option sellers want to be paid for.
2. The Q1 2026 print was strong, and the pipeline is loaded
Live Nation reported Q1 on May 5:
Revenue $3.79B, up 12% YoY (beat by ~$200M)
Adjusted operating income $371M, up 9%
Deferred event revenue $6.6B, a record, up $1.2B (22%) YoY
Over 85% of 2026 large-venue shows already booked through April
Tickets sold for 2026 concerts up 11% to over 107M
Management reiterated double-digit AOI growth guidance for 2026 and said the same compounding trajectory continues into future years. Guggenheim followed through by raising their price target to $197.
Translation: the operating business is firing. The legal case is being fought in a parallel universe to the one where 107 million people are buying concert tickets.
3. The Street is leaning into this name
Across 21 analysts, the consensus is Strong Buy with a 12-month price target around $181–183. The high estimate is $206 (Wolfe Research), the low is $140. Recent revisions have been almost universally upward; Guggenheim to $197, JPMorgan to $180, Roth to $190, UBS to $181.
For a stock to reach the $105 strike from here, it would need to fall below every single bearish analyst’s worst case and through the 52-week low. The trade is short the proposition that the Street is collectively wrong by 25%+ in the next four months.